TALLINN - The first week of free antibody-testing at the clinics of Estonian privately owned medical group Confido showed that less than one percent of those tested had developed antibodies to the coronavirus.
Altogether 1,079 antibody tests were carried out at Confido medical centers and walk-in clinics over the first week of June, in the course of which 10 people, or 0.9 percent, tested positive for IgG antibodies. Of the said 10 people, five had previously been diagnosed with the coronavirus on the basis of a nasopharyngeal swab. All those with IgG antibodies had experienced symptoms of COVID-19 over the past few months.
According to the information available to Confido, no widespread transmission has occurred in Estonia, which also means there is no herd immunity among the population and there is no other option but to await a vaccine for the virus.
The data collected with SARS-CoV-2 antibody rapid testing by Confido can be used in pseudonymized form by all public bodies and research institutions.